3-day vs. 1-day Low Residue Diet Influence in Colonoscopy Preparation and Patient Tolerability

NCT02955901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 412

Last updated 2019-07-16

No results posted yet for this study

Summary

Colonoscopy is one of the most common methods for the diagnosis and treatment of lower gastrointestinal tract diseases and provides a unique opportunity to identify early neoplastic lesions.

Adequate bowel preparation is important for optimal colonoscopy. New bowel-cleansing regimens, study of patient-related risk factors to fail a proper preparation and diet adaptations have been studied recently.

A low residue diet is the standard in the day before the colonoscopy. Some endoscopists prescribe this dietary plan for a 3-day period prior to the exam, although no study compared the recommended 1-day versus 3-day diet regime, or the influence in bowel preparation results.

The aim of this project is to determine if the use of a 3-day low residue diet improves bowel preparations results and the influence in patient tolerability and adherence.

Conditions

  • Colon Disease
  • Colonic Neoplasms

Interventions

OTHER

3 day low residue diet prior to the colonoscopy

3 day low residue diet prior to the colonoscopy

OTHER

1 day low residue diet prior to the colonoscopy

3 day low residue diet prior to the colonoscopy

Sponsors & Collaborators

  • Portuguese Oncology Institute, Coimbra

    lead OTHER

Principal Investigators

  • Filipe Taveira, MD · Portuguese Oncology Institute, Coimbra

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2018-12-31
Completion
2019-05-31

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02955901 on ClinicalTrials.gov